Álvaro Goyanes within the 1% of “Highly Cited Researchers 2023”

The list of Highly Cited Researchers 2023 includes a total of 6,849 outstanding researchers, where Álvaro Goyanes is the only representative from USC.

iMATUS researcher Álvaro Goyanes is the sole researcher from the University of Santiago de Compostela included (once again) in the prestigious ‘Highly Cited Researchers’ list for the year 2023, compiled by Web of Science. This select analysis, identifying researchers whose work ranks in the top 1% in their respective fields between 2012 and 2022, highlights Goyanes’s significant contribution to the field of 3D printing of personalized dosage medicines. With over 90 published articles and over 200 presentations at international conferences, his pioneering work in this field has been fundamental.

Apart from his distinguished academic career, Álvaro Goyanes is a co-founder of both FABRX, the first company specializing in 3D printing of personalized medicines, and FABRX Artificial Intelligence, a Galician company dedicated to employing artificial intelligence in pharmaceutical development.

His impact transcends borders, being an honorary professor at the Faculty of Pharmacy at University College London in the United Kingdom. Since 2019, Álvaro Goyanes has been recognized as a Highly Cited Researcher in the field of Pharmacology and Toxicology, establishing himself as a globally relevant figure in the scientific realm.

With a comprehensive evaluation considering a total of 188,500 articles, the recognition in the Highly Cited Researchers 2023 reaffirms Álvaro Goyanes’s commitment and significant contributions to advancing science and innovation in the pharmaceutical and health materials field.